INTRODUCTION
In vertebrates, the Aurora kinase family contains three different members, Aurora-A, -B and -C, that are associated with mitotic structures, such as spindle poles, centrosomes, chromosomes and the mid-body. Aurora-A is implicated in centrosome duplication/separation and spindle assembly. Interestingly, this kinase is amplified in human cancers, and its overexpression induces cell transformation (Bischoff et al., 1998; Zhou et al., 1998) , indicating that the control of Aurora-A levels is important in modulating cell division. In HeLa cells, Aurora-A is degraded and re-synthesized during cell-cycle transit (Honda et al., 2000) . Despite the fact that Aurora-A proteolysis seems to be essential for preventing cell transformation, the pathway that mediates its degradation is not known.
The ubiquitin-dependent pathway is a precise and rapid mechanism used by the cell to induce proteolysis. At the metaphase-anaphase and M-G 1 transitions, degradation is initiated by the E3/ubiquitin-ligase known as the anaphasepromoting complex (APC) (for a review, see Zachariae and Nasmyth, 1999) . This E3 is regulated by the Fizzy/Cdc20 and Fizzy-Related/Cdh1 proteins (Sigrist and Lehner, 1997; Fang et al., 1998; Lorca et al., 1998; Kramer et al., 2000) , two distinct activators that transiently interact with this ubiquitin ligase in a cell-cycle-specific manner. APC/Fizzy complex mediates securin and cyclin B degradation, a prerequisite for progression through mitosis (Cohen-Fix et al., 1996; Lorca et al., 1998) . Fizzy-Related mainly controls progression through G 1 by ensuring the complete proteolysis of cyclin B and Fizzy (Visintin et al., 1997; Pfleger and Kirschner, 2000) .
Here, we establish a further role for APC/Fizzy-Related at the M-G 1 transition, namely the ubiquitylation and thus degradation of Aurora-A in a D-Box-dependent manner.
RESULTS AND DISCUSSION
Aurora-A proteolysis is not mediated by the APC/Fizzy complex Similarly to human Aurora-A (Kimura et al., 1997; Bischoff et al., 1998) , Xenopus Aurora-A increases at the G 2 -M transition and then disappears at the M-G 1 transition of the cell cycle scientific report (see Supplementary figure 1 available at EMBO reports Online). Previously, Aurora-A was described to be degraded at metaphase II exit in Xenopus oocytes (Frank-Vaillant et al., 2000) , a transition regulated by APC/Fizzy (Lorca et al., 1998) . We investigated whether this reported decrease of Aurora-A is, in fact, mediated by this ubiquitin ligase. Using western blotting, we measured endogenous Aurora-A levels at different times following in vitro activation of APC/Fizzy by calcium addition to extracts prepared from Xenopus metaphase-II-arrested oocytes (CSF extracts). As expected, both Aurora-A and cyclin B2 were stable in the absence of calcium ( Figure 1A) . Surprisingly, the addition of Ca 2+ did not trigger Aurora-A proteolysis, whereas cyclin B2 was completely degraded. To confirm these results, we investigated whether endogenous Aurora-A was degraded in metaphase-II-arrested oocytes activated by the calcium ionophore A32187. Oocytes were homogenized at different times following ionophore treatment, and the levels of endogenous Aurora-A and cyclin B2 were analysed by immunoblotting. In contradiction to Frank-Vaillant et al. (2000) , endogenous Aurora-A levels were stable during the entire time course ( Figure 1B Figure 1C , lower panels). In contrast, cyclin B, a substrate of the APC/Fizzy-Related complex (Pfleger and Kirschner, 2000) , was proteolysed within 60 min of scientific report addition to Fizzy-Related-containing extracts, indicating that the latter was functional. Similarly, [ 35 S]Aurora-A was degraded 60 min after its addition ( Figure 1C , upper panels), suggesting a role for APC/Fizzy-Related in Aurora-A proteolysis. In a similar experiment, we examined the endogenous levels of this kinase by western blotting. Endogenous Aurora-A was completely degraded ∼60 min after the addition of Fizzy-Related mRNA, which led to the synthesis of Fizzy-Related ( Figure 1D ). In its absence, endogenous Aurora-A levels did not vary ( Figure 1D ). Fizzy, another APC/Fizzy-Related substrate (Pfleger and Kirschner, 2000) , also underwent complete degradation ( Figure 1D ). To determine whether or not Aurora-A degradation depended upon APC, interphase extracts were immunodepleted with anti-CDC27 antibodies before the addition of the Fizzy-Related mRNA ( Figure 2A, lower panel) . This blocked degradation of endogenous Aurora-A, whereas this kinase was entirely proteolysed when non-specific antibodies were used for immunodepletion ( Figure 2A ). Thus, APC mediates degradation of Aurora-A induced by Fizzy-Related expression.
Phosphorylation of Fizzy-Related by cyclin/cdk complexes inhibits APC/Fizzy-Related activity (Jaspersen et al., 1999; Blanco et al., 2000; Kramer et al., 2000) . To gain a deeper insight into the requirement of APC/Fizzy-Related complex to induce Aurora-A degradation, we added recombinant cyclin A to produce H1 kinase activity similar to that present in mitotic egg extracts. This led to a delay in Aurora-A proteolysis ( Figure 2B , middle panel), indicating that cyclin-A/cdk inhibited Aurora-A proteolysis, most likely through phosphorylation of Fizzy-Related.
Together, these results strongly suggest that Aurora-A proteolysis requires the APC complex and its activator Fizzy-Related.
The addition of a D-Box-motif-containing peptide blocks Aurora-A degradation
Substrates recognized by the APC contain a destruction signal sequence, often located near the N-terminus of target proteins. Two types of destruction sequences have been identified: the D-Box (RxxL, where 'x' is any amino acid) and the KEN-Box. D-Box-containing substrates typically appear to be recognized by both APC/Fizzy and APC/Fizzy-Related (Pfleger and Kirschner, 2000) . The KEN-Box-containing substrates are believed to be recognized exclusively by APC/Fizzy-Related. Recently, a novel extended D-Box has been reported to confer APC/Fizzy-and APC/Fizzy-Related-specific degradation signals to human cyclin A and Nek2A. This motif contains the core cyclin-B-type D-Box, followed by an additional short sequence at its extreme C-terminus (Hames et al., 2001) . N-terminal peptides of Xenopus and sea urchin cyclin B, containing the classic D-Box motif, inhibit the proteolytic activity of both APC/Fizzy and APC/Fizzy-Related by a competitive mechanism. Surprisingly, this works with substrates containing either the classic D-Box or KEN-Box motifs (Pfleger and Kirschner, 2000) but not those with the extended form of the D-Box motif (Hames et al., 2001) . Therefore, we added a cyclin B D-Box-containing peptide to interphase extracts supplemented previously with the Fizzy-Related mRNA and monitored endogenous Aurora-A levels. The peptide strongly delayed APC/Fizzy-Related-dependent proteolysis of Aurora-A, suggesting that this degradation is mediated by either D-Box or KEN-Box motifs ( Figure 2B , lower panel).
Aurora-A is degraded by a D-Box-dependent pathway
The Aurora-A protein sequence contains three potential D-Box motifs, D1 ( 212 RVYL), D2 ( 293 RTTL) and D3 ( 378 RLPL), and one potential KEN-Box motif near its N-terminus ( 6 KEN) ( Figure 3A) . The role of these destruction motifs on Aurora-A degradation has proved to be conflicting (Honda et al., 2000; Arlot-Bonnemains et al., 2001) . By using deleted forms of Xenopus Aurora-A, Arlot-Bonnemains et al. (2001) concluded that this kinase contains a destruction motif required for its ubiquitylation and degradation. In contrast, Honda et al. (2000) showed that punctual mutations or deletions of the putative D-Box sequences did not alter human Aurora-A degradation. To clarify whether a functional D-Box sequence is present in Aurora-A, we developed a (Control IP) and then complemented with Fizzy-Related mRNA. A sample of 2 µl was then taken at different times, and endogenous Aurora-A levels were analysed by western blotting. The initial interphase extract (CDC27, Int) and the supernatants of α-CDC27 (CDC27, SN Cdc 27) and non-specific (CDC27, SN Ct) immunoprecipitations were analysed by western blotting with α-CDC27 antibodies to verify CDC27 depletion. (B) Fizzy-Related mRNA was added to interphase extracts (50 µl); 20 min later, we added a purified recombinant cyclin A protein (2 ng/µl, +Cyclin A), the cyclin B D-Boxcontaining peptide (7 µg/µl, +DBox Peptide) or buffer (CT). Endogenous levels of Aurora-A were then analysed by western blotting at different times.
scientific report punctual mutation analysis of putative D-Box motifs in our assay, where the degradation of this kinase can selectively be induced by the addition of Fizzy-Related mRNA. Thus, the three arginine ( 212 R, 293 R and 378 R) and leucine ( 215 L, 296 L and 381 L) residues of each potential D-Box sequence were mutated to alanine (A). We then tested the degradation of the 35 S-labelled mutated forms translated in reticulocyte lysates when added to Fizzy-Related-containing interphase extracts. We also analysed proteolysis of an Aurora-A kinase mutant lacking the KEN-Box motif ( 6 KEN). The deletion of the KEN-Box motif did not affect Aurora-A stability ( Figure 3B ), nor did mutations of either D-Box 1 or D-Box 2 motifs ( Figure 3C , upper and middle panels). However, a mutated D-Box 3 stabilized Aurora-A in this assay ( Figure 3C, lower panel) . We conclude that the D-Box 3 sequence of Aurora-A mediates its degradation. A ∆36-44 truncated form of Xenopus cyclin B has been reported to be ubiquitylated in vitro by APC/Fizzy-Related and not APC/Fizzy (Pfleger and Kirschner, 2000) . This process is mediated by the recognition of the D-Box motif at position 7-15 of this protein. However, the authors found that a deleted form of cyclin B lacking this D-Box sequence was degraded to the same extent as wild-type protein by both APC/Fizzy and APC/Fizzy-Related. Therefore, the partial ubiquitylation dependent on APC/FizzyRelated of cyclin B observed in vitro is not involved in physiological degradation of this protein. Thus, to our knowledge, this is the first example of a protein whose degradation is D-Box-dependent, at least in Xenopus egg extracts, and is exclusively mediated by APC/Fizzy-Related.
The APC/Fizzy-Related complex ubiquitylated wild type but not a D-Box 3 mutant of Aurora-A To understand how mutation of the D-Box 3 motif blocks Aurora-A degradation, we tested whether this mutant is ubiquitylated in vitro by the APC/Fizzy-Related complex. Our in vitro ubiquitylation assay uses APC immunoprecipitated from interphase Xenopus egg extracts with α-CDC27 antibodies. This complex was incubated with 35 S-labelled wild type or a D-Box 3 mutated form of Aurora-A translated in reticulocyte lysates, along with E2, Ubch5B and bovine ubiquitin. Finally, the ubiquitylation assay was performed in the presence or absence of in vitro translated Fizzy-Related activator. As shown in Figure 3D , wild-type Aurora-A became strongly ubiquitylated only when both APC and recombinant Fizzy-Related were present in the reaction mixture (compare the first two lanes). Thus, Fizzy-Related is required for efficient APC-mediated ubiquitylation of Aurora-A. Furthermore, mutation of D-Box 3 blocked Aurora-A ubiquitylation, indicating that an intact D-Box 3 motif is essential, in our assay system, for its in vitro ubiquitylation ( Figure 3D , right-hand lane).
Ectopic expression of Fizzy-Related by mRNA microinjection induces Aurora-A degradation in G 2 -arrested oocytes
In quiescent Xenopus oocytes, Aurora-A is already present at stage VI oocytes, and no significant decrease in its levels has ever been observed during oocyte maturation. This is consistent with the lack of Fizzy-Related in Xenopus oocytes. We exploited this physiological situation to investigate whether the ectopic expression of Fizzy-Related could induce endogenous Aurora-A degradation in vivo. Stage VI oocytes were injected with Fizzy-Related mRNA. At different times, five oocytes were individually homogenized and analysed by western blotting for the presence or absence of Fizzy-Related and Aurora-A. We also followed the degradation of endogenous 
METHODS
Immunization procedure, antibodies and immunofluorescence microscopy. A wild-type Xenopus His 6 -Aurora-A fusion protein, produced in Escherichia coli, was used to immunize rabbits. Immune serum was affinity-purified on immobilized His 6 -Aurora-A. The Xenopus anti-cyclin B2, anti-Fizzy, anti-CDC27 and antiFizzy-Related antibodies have been described previously (Lorca et al., 1998; Castro et al., 2001) . Immunofluorescence assays were developed as described previously (Roghi et al., 1998) . Translation and degradation in Xenopus egg extracts. Interphase and CSF extracts, as well as extracts competent in translation of Xenopus Fizzy-Related mRNA, were prepared as described previously (Fesquet et al., 1997; Lorca et al., 1998) . For protein degradation assays, 1 µl of either 35 S-labelled cyclin B or Aurora-A was incubated at room temperature with 20 µl interphase extracts supplemented (1 h before) or not with Fizzy-Related mRNA. In vitro ubiquitylation assay. Wild-type and mutated (R398A-L401A) Aurora-A proteins were translated in vitro in rabbit reticulocyte lysates in the presence of [ 35 S]methionine. To obtain APC/Fizzy-Related complexes, APC was immunopurified from interphase Xenopus egg extracts with anti-CDC27 antibodies and activated by reticulocyte-lysate-expressed Xenopus Fizzy-Related. The in vitro ubiquitylation reaction was performed as reported previously (Bembenek and Yu, 2001) . mRNA microinjection in Xenopus oocytes. Fifty oocytes were microinjected with 20 ng Fizzy-Related mRNA. Each hour, five oocytes were homogenized individually in 10 µl homogenization buffer (20 mM Tris pH 7.5, 50 mM NaCl, 50 mM NaF, 10 mM β-glycerophosphate, 5 mM Na 4 P 2 O 7 , 1 mM EDTA). After extract centrifugation (13 000 r.p.m. for 3 min at 4°C), the clear supernatant was recovered and used for western blotting.
Site-directed mutagenesis. Oligonucleotides D1 (5′-GGCTATTTC-CACGATGCTTCCGCAGTCTACGCAATCCTGGATTATGCCC-3′) (5′-GGGCATAATCCAGGATTGCGTAGACTGCGGAAGCAT-CGTGGAAATAGCC-3′), D2 (5′-CATGCTCCATCCTCCAGGGC-GACCACTGCGTGTGGAACACTGGAC-3′) (5′-GTCCAGTGTTC-CACACGCAGTGGTCGCCCTGGAGGATGGAGCATG-3′) and D3 (5′-CACAACCCAAACCACGCGCTGCCAGCGAAAGGGGT-TCTCGAAC-3′) (5′-GTTCGAGAACCCCTTTCGCTGGCAGCG-CGTGGTTTGGGTTGTG-3′) were used for site-directed mutagenesis of D-Box 1, 2 and 3, respectively, according to the manufacturer's recommendations (Stratagene). Deletion of the KEN-Box has been described previously (Arlot-Bonnemains et al., 2001) . All constructs were verified by sequencing. Homogenates were prepared from individual oocytes hourly and analysed by coupled western blotting in the same nitrocellulose membrane for endogenous Aurora-A and Fizzy-Related. Fizzy degradation was followed by western blotting on a separate membrane.
